In-Kyu Yoon | Deputy Director General
International Vaccine Institute

In-Kyu Yoon, Deputy Director General, International Vaccine Institute

In-Kyu Yoon, M.D. is based in Seoul, South Korea, and serves as Deputy Director General of Integrated Development & Pandemic/Outbreak Readiness at the International Vaccine Institute (IVI). He previously served as Executive Director of Research & Development (acting) at the Coalition for Epidemic Preparedness Innovations (CEPI); Director and Global Head of Programmes and Innovative Technology at CEPI; Deputy Director General of Science at IVI in Seoul, South Korea; Director of the Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC) and Dengue Vaccine Initiative (DVI); and Chief of Virology at the U.S. Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand. Dr. Yoon has conducted research on the epidemiology, pathophysiology and immunology of infectious diseases including dengue, Zika, chikungunya, MERS and influenza, and has authored over 140 publications in peer-reviewed journals. He has overseen vaccine development programs for numerous diseases such as COVID-19, dengue, Lassa fever, Nipah and MERS, and has led international public health initiatives in support of vaccine introduction efforts. He was a faculty member of the Uniformed Services University, USA, and is Fellow of the American College of Physicians. Dr. Yoon graduated magna cum laude with a Bachelor of Science degree in Paleobiology from Yale University, and received his Doctor of Medicine from New York University School of Medicine. He completed residency in Internal Medicine and a fellowship in Allergy/Immunology at Walter Reed Army Medical Center, USA.

Appearances:



Main Conference Day 1 - 9th March @ 09:30

Keynote Panel: Are We Ready for the Next Outbreak? Reconciling Surveillance, Diagnostics, and the MCM Pipeline

    obal health architecture excels at planning for hypothetical pandemics, but often falters during localized, sporadic outbreaks of high-consequence pathogens like Ebola, Marburg, and Hantavirus. This plenary session bridges the gap between early detection and rapid immunization, evaluating how the international community can align diagnostic infrastructure and regulatory frameworks to deploy life-saving vaccines before outbreaks spiral out of control. 
  •     The Strategic Dilemma: Multi-Pathogen Platforms vs. Target-Specific Vaccines vs. Host-directed therapies
  •     The Diagnostic-to-Vaccine Trigger: Resolving Operational Bottlenecks
  •     Pre-Outbreak Deployment Protocols & Clinical Trial Readiness – Regulatory Bottlenecks
  •     Field Reality vs. Scientific Ambition: Supply Chains, Cold Chains and Public Trust 

last published: 31/Aug/26 19:45 GMT

back to speakers